Search Results - "Rasmussen, Peter V"

The impact of quality of life on treatment preferences in multiple sclerosis patients by Lee Mortensen, Gitte, Rasmussen, Peter V

“…Multiple sclerosis (MS) is a demyelinating disorder with an unpredictable and often disabling course. MS symptoms are very heterogeneous and may lead to…”
Get full text

Electrocardiographic Tpeak–Tend interval and risk of cardiovascular morbidity and mortality: Results from the Copenhagen ECG study by Bachmann, Troels N., BSc, Skov, Morten W., MD, Rasmussen, Peter V., BSc, Graff, Claus, MSc, PhD, Pietersen, Adrian, MD, Lind, Bent, MD, DMSci, Struijk, Johannes J., MSc, PhD, Olesen, Morten S., MSc, PhD, Haunsø, Stig, MD, DMSci, Køber, Lars, MD, DMSci, Svendsen, Jesper H., MD, DMSci, Holst, Anders G., MD, PhD, Nielsen, Jonas B., MD, PhD

“…Background The electrocardiographic Tpeak–Tend interval is considered a novel risk marker of cardiac arrhythmias and cardiovascular death; however, results to…”
Get full text

Risk Prediction of Atrial Fibrillation Based on Electrocardiographic Interatrial Block by Skov, Morten W., Ghouse, Jonas, Kühl, Jørgen T., Platonov, Pyotr G., Graff, Claus, Fuchs, Andreas, Rasmussen, Peter V., Pietersen, Adrian, Nordestgaard, Børge G., Torp‐Pedersen, Christian, Hansen, Steen M., Olesen, Morten S., Haunsø, Stig, Køber, Lars, Gerds, Thomas A., Kofoed, Klaus F., Svendsen, Jesper H., Holst, Anders G., Nielsen, Jonas B.

“…Background The electrocardiographic interatrial block (IAB) has been associated with atrial fibrillation (AF). We aimed to test whether IAB can improve risk…”
Get full text

Association Between Heart Rate at Rest and Incident Atrial Fibrillation (from the Copenhagen Electrocardiographic Study) by Skov, Morten W., Bachmann, Troels N., Rasmussen, Peter V., Olesen, Morten S., Pietersen, Adrian, Graff, Claus, Lind, Bent, Struijk, Johannes J., Køber, Lars, Haunsø, Stig, Svendsen, Jesper H., Gerds, Thomas A., Holst, Anders G., Nielsen, Jonas B.

“…Heart rate (HR) at rest is a well-known marker of cardiovascular morbidity and mortality. Results on the association between HR and incident atrial…”
Get full text

Brugada Syndrome-Associated Genetic Loci Are Associated With J-Point Elevation and an Increased Risk of Cardiac Arrest by Andreasen, Laura, Ghouse, Jonas, Skov, Morten W, Have, Christian T, Ahlberg, Gustav, Rasmussen, Peter V, Linneberg, Allan, Pedersen, Oluf, Platonov, Pyotr G, Haunsø, Stig, Svendsen, Jesper H, Hansen, Torben, Kanters, Jørgen K, Olesen, Morten S

“…A previous genome-wide association study found three genetic loci, rs9388451, rs10428132, and rs11708996, to increase the risk of Brugada Syndrome (BrS). Since…”
Get full text

Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study by Mahler, Mie Reith, Magyari, Melinda, Pontieri, Luigi, Elberling, Frederik, Holm, Rolf Pringler, Weglewski, Arkadiusz, Poulsen, Mai Bang, Storr, Lars Kristian, Bekyarov, Plamen Anzhelov, Illes, Zsolt, Kant, Matthias, Sejbaek, Tobias, Stilund, Morten Leif, Rasmussen, Peter V, Brask, Maria, Urbonaviciute, Inga, Sellebjerg, Finn

“…BackgroundClinicians frequently rely on relapse counts, T2 MRI lesion load (T2L) and Expanded Disability Status Scale (EDSS) scores to guide treatment…”
Get full text

Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study by Pontieri, Luigi, Blinkenberg, Morten, Bramow, Stephan, Papp, Viktoria, Rasmussen, Peter V., Kant, Matthias, Schäfer, Jakob, Mathiesen, Henrik K., Jensen, Michael B., Sirakov, Georgi, Berg, Jonas M., Kopp, Tine I., Joensen, Hanna, Sellebjerg, Finn, Magyari, Melinda

“…Background and purpose Real‐world evidence regarding the effectiveness and safety of ocrelizumab for the treatment of multiple sclerosis (MS) is limited. The…”
Get full text

Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry by Theodorsdottir, Asta, Debrabant, Birgit, Magyari, Melinda, Kant, Matthias, Rasmussen, Peter V, Malmberg, Carl-Fredrik, Norberg, Iver A, Hansen, Victoria, Bech, Danny, Schmidt, Mathias F, Schreiber, Karen, Frederiksen, Jette L, Sellebjerg, Finn, Illes, Zsolt

“…Objective: To investigate clinical outcomes in a real-world setting in the complete population-based cohort of alemtuzumab-treated MS patients in Denmark…”
Get full text

Risk prediction of cardiovascular death based on the QTc interval: evaluating age and gender differences in a large primary care population by Nielsen, Jonas B, Graff, Claus, Rasmussen, Peter V, Pietersen, Adrian, Lind, Bent, Olesen, Morten S, Struijk, Johannes J, Haunsø, Stig, Svendsen, Jesper H, Køber, Lars, Gerds, Thomas A, Holst, Anders G

“…Using a large, contemporary primary care population we aimed to provide absolute long-term risks of cardiovascular death (CVD) based on the QTc interval and to…”
Get full text

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study by Dalgaard, Frederik, Pieper, Karen, Verheugt, Freek, Camm, A John, Fox, Keith AA, Kakkar, Ajay K, Pallisgaard, Jannik L, Rasmussen, Peter V, Weert, Henk van, Lindhardt, Tommi Bo, Torp-Pedersen, Christian, Gislason, Gunnar H, Ruwald, Martin H, Harskamp, Ralf E

“…ObjectivesTo externally validate the accuracy of the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) model against existing risk…”
Get full text

Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality: Results From the Copenhagen ECG Study by Skov, Morten W, Rasmussen, Peter V, Ghouse, Jonas, Hansen, Steen M, Graff, Claus, Olesen, Morten S, Pietersen, Adrian, Torp-Pedersen, Christian, Haunsø, Stig, Køber, Lars, Svendsen, Jesper H, Holst, Anders G, Nielsen, Jonas B

“…BACKGROUND—The majority of available data on the clinical course of patients with ventricular preexcitation in the ECG originates from tertiary centers. We…”
Get full text

Personalised inpatient multidisciplinary rehabilitation elicits clinically relevant improvements in physical function in patients with multiple sclerosis – The Danish MS Hospitals Rehabilitation Study by Hvid, Lars G, Gaemelke, Tobias, Dalgas, Ulrik, Slipsager, Mette K, Rasmussen, Peter V, Petersen, Thor, Nørgaard, Michael, Skjerbaek, Anders G, Boesen, Finn

“…Purpose Evidence of the effects of inpatient multidisciplinary rehabilitation (MDR) on physical function in patients with multiple sclerosis (MS) is limited,…”
Get full text

TDM-based imipramine treatment in neuropathic pain by Rasmussen, Peter V, Jensen, Troels S, Sindrup, Søren H, Bach, Flemming W

“…Tricyclic antidepressants (TCA) are the best-documented treatment of neuropathic pain. TCAs have a pronounced interindividual pharmacokinetic variability and a…”
Get full text

A hazard ratio above one does not necessarily mean higher risk, when using a time-dependent cox model by Blanche, Paul, Zareini, Bochra, Rasmussen, Peter V

“…The Cox model is one of the most used statistical models in medical research. It models the hazard rate of an event and its association with covariates through…”
Get full text

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies by Andersen, Johanna B, Sharmin, Sifat, Lefort, Mathilde, Koch-Henriksen, Nils, Sellebjerg, Finn, Sørensen, Per Soelberg, Hilt Christensen, Claudia C, Rasmussen, Peter V, Jensen, Michael B, Frederiksen, Jette L, Bramow, Stephan, Mathiesen, Henrik K, Schreiber, Karen I, Horakova, Dana, Havrdova, Eva K, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Trojano, Maria, McCombe, Pamela, Slee, Mark, Lechner-Scott, Jeannette, Turkoglu, Recai, Sola, Patrizia, Ferraro, Diana, Granella, Franco, Shaygannejad, Vahid, Prevost, Julie, Skibina, Olga, Solaro, Claudio, Karabudak, Rana, Wijmeersch, Bart V, Csepany, Tunde, Spitaleri, Daniele, Vucic, Steve, Casey, Romain, Debouverie, Marc, Edan, Gilles, Ciron, Jonathan, Ruet, Aurélie, Sèze, Jérôme D, Maillart, Elisabeth, Zephir, Hélène, Labauge, Pierre, Defer, Gilles, Lebrun, Christine, Moreau, Thibault, Berger, Eric, Clavelou, Pierre, Pelletier, Jean, Stankoff, Bruno, Gout, Olivier, Thouvenot, Eric, Heinzlef, Olivier, Al-Khedr, Abdullatif, Bourre, Bertrand, Casez, Olivier, Cabre, Philippe, Montcuquet, Alexis, Wahab, Abir, Camdessanché, Jean-Philippe, Marousset, Aude, Patry, Ivania, Hankiewicz, Karolina, Pottier, Corinne, Maubeuge, Nicolas, Labeyrie, Céline, Nifle, Chantal, Leray, Emmanuelle, Laplaud, David A, Butzkueven, Helmut, Kalincik, Tomas, Vukusic, Sandra, Magyari, Melinda

“…Natalizumab and fingolimod were the first preparations recommended for disease breakthrough in priorly treated relapsing-remitting multiple sclerosis. Of three…”
Get full text

Association Between Resting Heart Rate and Incident Atrial Fibrillation (From the Copenhagen ECG study) by Skov, Morten W., MD, Bachmann, Troels N., BSc, Rasmussen, Peter V., MD, Olesen, Morten S., PhD, Pietersen, Adrian, MD, Graff, Claus, PhD, Lind, Bent, DMSci, Struijk, Johannes J., PhD, Køber, Lars, DMSci, Haunsø, Stig, DMSci, Svendsen, Jesper H., DMSci, Gerds, Thomas A., PhD, Holst, Anders G., PhD, Nielsen, Jonas B., PhD

“…Abstract Resting heart rate (HR) is a well-known marker of cardiovascular morbidity and mortality. Results on the association between HR and incident atrial…”
Get full text

Response letter regarding Thompson 00258 by Bach, Flemming W., Jensen, Troels S., Sindrup, Søren H., Rasmussen, Peter V.

Get full text

Letter to the Editor of PAIN by Thompson, Ellen Nergard

Get full text